Lyrica (pregabalin) is a prescription nerve medication used to treat several types of chronic pain, seizures, and fibromyalgia. It has five FDA-approved uses and works by calming overactive nerve signals in the brain and spinal cord. It’s classified as a Schedule V controlled substance, meaning it carries a low but real potential for dependence.
How Lyrica Works
Lyrica targets nerve cells that have become hyperexcited, which is the underlying problem in nerve pain, seizures, and conditions like fibromyalgia. It attaches to a specific part of calcium channels on nerve cells, reducing the flow of calcium into the nerve terminal. Less calcium means the nerve releases fewer excitatory chemical signals.
What makes Lyrica distinctive is that it’s “state dependent.” It primarily affects nerves that are firing too much, dialing them back toward normal activity. Nerves that are functioning normally are largely left alone. This selectivity helps explain why it works across several different conditions that share the common thread of overactive nerve signaling.
FDA-Approved Uses
Diabetic Nerve Pain
Lyrica is approved to treat the burning, tingling, or stabbing pain caused by nerve damage from diabetes, known as diabetic peripheral neuropathy. This is one of its most common uses. In clinical trials, about 88% of patients on Lyrica experienced a meaningful improvement in pain after 12 weeks. Roughly 58% of patients saw their pain cut in half or more over that period, with average pain scores dropping by 35 to 42 points on a 100-point scale. Most patients who respond notice improvement beginning within the first few weeks.
Pain After Shingles
Postherpetic neuralgia is the persistent nerve pain that can linger for months or years after a shingles outbreak. Lyrica is approved to manage this type of pain. Treatment typically starts at a lower dose and can be increased over several weeks if needed. Patients who don’t get enough relief after two to four weeks at a moderate dose may be moved to a higher one.
Fibromyalgia
Lyrica was the first medication approved specifically for fibromyalgia, a condition marked by widespread pain, fatigue, and sleep problems. In a 14-week trial, patients taking Lyrica experienced significantly greater pain reduction compared to placebo at all three doses tested. All three doses also improved sleep quality, which is notable because poor sleep is one of the most disruptive symptoms of fibromyalgia. The effective dose range for this condition is typically 300 to 450 mg per day.
Spinal Cord Injury Pain
Nerve pain following a spinal cord injury can be especially difficult to treat. Lyrica is approved for this use at doses ranging from 150 to 600 mg per day. As with its other indications, treatment starts at the lower end and is gradually increased based on how well it works and how well you tolerate it.
Partial-Onset Seizures
Lyrica is used as an add-on treatment (not a standalone medication) for partial-onset seizures in patients one month of age and older. In adults, the starting dose is typically 150 mg per day, with a maximum of 600 mg per day. This is the only approved use in young children.
Common Side Effects
Dizziness and drowsiness are by far the most frequent side effects. In clinical trials, 30% of adults taking Lyrica experienced dizziness (compared to 8% on placebo), and 23% experienced drowsiness (also compared to 8% on placebo). These effects tend to be most noticeable when starting the medication or increasing the dose.
Other side effects that occurred in at least 5% of adults, and at more than twice the rate of placebo, include dry mouth, swelling in the hands or feet, blurred vision, weight gain, and difficulty concentrating. In children taking Lyrica for seizures, the most common side effects were increased weight and increased appetite.
Controlled Substance Status
Lyrica is a Schedule V controlled substance, the lowest level of control. The DEA placed it in this category because clinical trials showed an unusually high percentage of participants experiencing euphoria. Preclinical studies also found that lab animals would self-administer the drug, though at much lower rates than they would with sedatives like pentobarbital. Lyrica can produce effects similar to anti-anxiety medications like diazepam and alprazolam, which is part of why it carries abuse potential despite its relatively low classification.
This means your pharmacy will track refills and your prescriber may monitor your use more closely than with a non-controlled medication.
Stopping Lyrica Safely
Lyrica should not be stopped abruptly. Withdrawal symptoms can include severe anxiety, panic, nausea, and insomnia. Some people report symptoms that feel worse than the original condition they were treating. Tapering too quickly can cause significant problems.
A typical approach involves reducing your dose gradually over weeks to months, dropping by one dose level and waiting at least two weeks (sometimes longer) before reducing again. Some people need a month or more at each step to adjust comfortably. Your prescriber will set a tapering schedule based on your current dose and how long you’ve been on the medication, but the key principle is that slower is generally safer and more comfortable.
Off-Label Uses
Doctors sometimes prescribe Lyrica for conditions beyond its five approved uses. Generalized anxiety disorder is one of the most common off-label applications. Lyrica is actually approved for anxiety in Europe, though not in the United States. Its mechanism of reducing excitatory nerve signaling in overactive neurons is thought to underlie its calming effects. Restless legs syndrome is another condition where Lyrica has been explored, though large-scale clinical evidence remains limited.